0.6372
+0.0333
+(5.51%)
As of 12:32:52 PM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 3 |
| Avg. Estimate | -0.18 | -0.18 | -0.72 | -0.76 |
| Low Estimate | -0.19 | -0.19 | -0.79 | -0.87 |
| High Estimate | -0.16 | -0.17 | -0.61 | -0.67 |
| Year Ago EPS | -0.18 | -0.19 | -0.7 | -0.72 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 8 | 8 | 8 | 8 |
| Avg. Estimate | 15.92M | 16.03M | 63.85M | 63.11M |
| Low Estimate | -- | -- | -- | 24M |
| High Estimate | 30.7M | 32.5M | 130.12M | 132.74M |
| Year Ago Sales | 21.64M | 23.49M | 98.43M | 63.85M |
| Sales Growth (year/est) | -26.45% | -31.77% | -35.13% | -1.15% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.2 | -0.2 | -0.21 | -0.19 |
| EPS Actual | -0.18 | -0.19 | -0.18 | -0.15 |
| Difference | 0.02 | 0.01 | 0.03 | 0.05 |
| Surprise % | 10.24% | 6.73% | 14.26% | 23.08% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.18 | -0.18 | -0.72 | -0.76 |
| 7 Days Ago | -0.18 | -0.18 | -0.72 | -0.76 |
| 30 Days Ago | -0.21 | -0.2 | -0.86 | -0.85 |
| 60 Days Ago | -0.21 | -0.2 | -0.86 | -0.85 |
| 90 Days Ago | -0.21 | -0.2 | -0.86 | -0.85 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | -- | -- |
| Up Last 30 Days | 1 | 1 | 2 | 2 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| NKTR | 1.32% | 2.46% | -2.43% | -6.52% |
| S&P 500 | 6.76% | 5.73% | 9.19% | 14.14% |
Upgrades & Downgrades
| Upgrade | Jefferies: Hold to Buy | 4/11/2025 |
| Upgrade | Oppenheimer: Perform to Outperform | 3/14/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/13/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 2/25/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/13/2025 |
| Initiated | B. Riley Securities: Buy | 1/8/2025 |
Related Tickers
LXEO Lexeo Therapeutics, Inc.
2.3500
+9.81%
CYTK Cytokinetics, Incorporated
38.63
-2.96%
SWTX SpringWorks Therapeutics, Inc.
37.23
-0.61%
BBIO BridgeBio Pharma, Inc.
34.08
-2.21%
SGMO Sangamo Therapeutics, Inc.
0.7349
-2.08%
TRVI Trevi Therapeutics, Inc.
5.98
+0.42%
ATYR aTyr Pharma, Inc.
2.9900
-0.66%
THRD Third Harmonic Bio, Inc.
5.13
+0.85%
NUVB Nuvation Bio Inc.
1.9990
-1.04%
MREO Mereo BioPharma Group plc
1.9550
+2.90%